NAPANEE, Ontario, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned ...
TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in ...
Lophos Pharmaceuticals Corp. completes the planting of 3,000 peyote seeds, signifying a significant expansion in cultivation efforts. The milestone exceeds the initial target of 1,000 plants for 2024, ...
VANCOUVER, British Columbia, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is delighted to share a substantial milestone. Its wholly owned subsidiary, ...
Toronto, Ontario--(Newsfile Corp. - March 21, 2022) - Lophos Pharmaceuticals Inc., a Canadian psychedelic research company focused on cultivation and drug development, engages KGK Science Inc. to ...
VANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. ("ThreeD"), a publicly traded Canadian-based venture capital firm focused on opportunistic investments in companies ...
VANCOUVER, British Columbia, July 01, 2026 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos" or the "Company") (CSE: MESC), a Canadian bioscience company focused on regulated plant-based and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results